In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT1B/1D/2 receptor antagonist properties
2001
Abstract 1-[2-[4-(6-fluoro-1 H -indol-3-yl)-3,6-dihydro-1(2 H )-pyridinyl]ethyl]-3-isopropyl-6-(methylsulphonyl)-3,4-dihydro-1 H -2,1,3-benzothiadiazine-2,2-dioxide (LY393558) is a potent inhibitor of [ 3 H]5-hydroxytryptamine ([ 3 H]5-HT) uptake into rat cortical synaptosomes (pIC 50 =8.48±0.12). It produces a dextral shift of the 5-HT dose–response curves for the binding of GTPγ[ 35 S] to human 5-HT 1B (p K b =9.05±0.14) and 5-HT 1D (p K b =8.98±0.07) receptors and inhibits the contractile response of the rabbit saphenous vein to the 5-HT 1B/D receptor agonist, sumatriptan (p K b =8.4±0.2). In addition, it is an antagonist at the 5-HT 2A (p K i =7.29±0.19) and 5-HT 2B (p K i =7.35±0.11) receptors. Presynaptic autoreceptor antagonist activity was demonstrated by its ability to potentiate the K + -induced outflow of [ 3 H]5-HT from guinea pig cortical slices (pEC 50 =7.74±0.05 nM) in which the 5-HT transporter had been inhibited by a maximally effective concentration of paroxetine. It is concluded that LY393558 should be an effective antidepressant with the potential to produce an earlier onset of efficacy than selective serotonin uptake inhibitors.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
48
References
13
Citations
NaN
KQI